{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:06:03Z","timestamp":1753520763164,"version":"3.40.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02475-6","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T10:30:05Z","timestamp":1747305005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring non-coding RNA expression profiles of AKR1B10P1, RP11-465B22.3, WASH8P, and NPM1P25 as a predictive model for hepatocellular carcinoma patient survival"],"prefix":"10.1007","volume":"16","author":[{"given":"Khatereh","family":"Firouzi-Farsani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Dehghani-Samani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razieh","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reihaneh","family":"Sadat Moosavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mahdevar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"1","key":"2475_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2475_CR2","doi-asserted-by":"publisher","first-page":"e3089","DOI":"10.7717\/peerj.3089","volume":"5","author":"H Yang","year":"2017","unstructured":"Yang H, Zhang X, Cai X, Wen D, Ye Z, Liang L, et al. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma. PeerJ. 2017;5:e3089.","journal-title":"PeerJ"},{"issue":"66","key":"2475_CR3","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.18632\/oncotarget.22161","volume":"8","author":"S Chen","year":"2017","unstructured":"Chen S, Zhu J, Wang F, Guan Z, Ge Y, Yang X, et al. LncRNAs and their role in cancer stem cells. Oncotarget. 2017;8(66):110685.","journal-title":"Oncotarget"},{"issue":"11","key":"2475_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253\u201361.","journal-title":"Nat Med"},{"key":"2475_CR5","doi-asserted-by":"publisher","first-page":"119950","DOI":"10.1016\/j.lfs.2021.119950","volume":"285","author":"M Mahdevar","year":"2021","unstructured":"Mahdevar M, Vatandoost J, Forootan FS, Kiani-Esfahani A, Esmaeili M, Peymani M, et al. Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway. Life Sci. 2021;285:119950.","journal-title":"Life Sci"},{"key":"2475_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2017.07.031","volume":"407","author":"Y Kong","year":"2017","unstructured":"Kong Y, Zhang L, Huang Y, He T, Zhang L, Zhao X, et al. Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway. Cancer Lett. 2017;407:76\u201383.","journal-title":"Cancer Lett"},{"key":"2475_CR7","doi-asserted-by":"crossref","unstructured":"Han K, Li C, Zhang X, Shang L. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt\/\u03b2-catenin and PI3K\/Akt signaling pathways. Biosci Rep. 2019;39(5):BSR20181457.","DOI":"10.1042\/BSR20181457"},{"issue":"14","key":"2475_CR8","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.3390\/ijms22147614","volume":"22","author":"J Lee","year":"2021","unstructured":"Lee J, Hwang J-H, Chun H, Woo W, Oh S, Choi J, et al. PLEKHA8P1 promotes tumor progression and indicates poor prognosis of liver cancer. Int J Mol Sci. 2021;22(14):7614.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2475_CR9","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1038\/s41598-022-15251-1","volume":"12","author":"G Zhang","year":"2022","unstructured":"Zhang G, Sun J, Zhang X. A novel cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma. Sci Rep. 2022;12(1):11325.","journal-title":"Sci Rep"},{"issue":"6","key":"2475_CR10","first-page":"5237","volume":"19","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhang F, Wang L, Song X, Jing J, Zhang F, et al. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma. Mol Med Rep. 2019;19(6):5237\u201350.","journal-title":"Mol Med Rep"},{"issue":"8","key":"2475_CR11","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"key":"2475_CR12","doi-asserted-by":"crossref","unstructured":"Law CW, Alhamdoosh M, Su S, Dong X, Tian L, Smyth GK, et al. RNA-seq analysis is easy as 1\u20132\u20133 with limma, Glimma and edgeR. F1000Research. 2016;5.","DOI":"10.12688\/f1000research.9005.1"},{"issue":"3","key":"2475_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2475_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/jmedgenet-2014-102785","volume":"52","author":"L Xiao-Jie","year":"2015","unstructured":"Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X. Pseudogene in cancer: real functions and promising signature. J Med Genet. 2015;52(1):17\u201324.","journal-title":"J Med Genet"},{"key":"2475_CR15","doi-asserted-by":"crossref","unstructured":"Sisu C. Pseudogenes as biomarkers and therapeutic targets in human cancers. Pseudogenes: Pseudogenes: Functions and\nProtocols. 2021. p. 319\u201337.","DOI":"10.1007\/978-1-0716-1503-4_20"},{"key":"2475_CR16","doi-asserted-by":"crossref","unstructured":"Bao L, Li P, Zhao H, Chen L, Wang Y, Liang S, et al. Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324\u20133p\/GLYATL1 axis. Digest Liver Dis. 2021;54(7):918-26.","DOI":"10.1016\/j.dld.2021.10.003"},{"issue":"1","key":"2475_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12876-022-02475-8","volume":"22","author":"Y-M Ning","year":"2022","unstructured":"Ning Y-M, Lin K, Liu X-P, Ding Y, Jiang X, Zhang Z, et al. NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma. BMC Gastroenterol. 2022;22(1):392.","journal-title":"BMC Gastroenterol"},{"issue":"16","key":"2475_CR18","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.3390\/cells11162610","volume":"11","author":"Y-H Lin","year":"2022","unstructured":"Lin Y-H, Liu Y-C, Chen C-Y, Chi H-C, Wu M-H, Huang P-S, et al. LPAL2 suppresses tumor growth and metastasis of hepatocellular carcinoma by modulating MMP9 expression. Cells. 2022;11(16):2610.","journal-title":"Cells"},{"issue":"1","key":"2475_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5114\/aoms.2020.100675","volume":"17","author":"J Liu","year":"2021","unstructured":"Liu J, Chen L, Pan J, Chen M, Zhou J, Zhou F, et al. Comprehensive analysis of key lncRNAs in HCV-positive hepatocellular carcinoma. Arch Med Sci AMS. 2021;17(1):142.","journal-title":"Arch Med Sci AMS"},{"issue":"13","key":"2475_CR20","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1007\/s00432-023-05099-x","volume":"149","author":"S Xu","year":"2023","unstructured":"Xu S, Dong K, Gao R, Yang Y, Zhou Y, Luo C, et al. Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(13):12249\u201363.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"2475_CR21","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy JK, Sambasiva RM. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol-Gastrointest Liver Physiol. 2006;290(5):G852\u20138.","journal-title":"Am J Physiol-Gastrointest Liver Physiol."},{"issue":"4","key":"2475_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/hep-2016-0012","volume":"3","author":"M Wang","year":"2016","unstructured":"Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, et al. Dysregulated fatty acid metabolism in hepatocellular carcinoma. Hepat Oncol. 2016;3(4):241\u201351.","journal-title":"Hepat Oncol"},{"issue":"20","key":"2475_CR23","doi-asserted-by":"publisher","first-page":"11779","DOI":"10.1111\/jcmm.15790","volume":"24","author":"F Hao","year":"2020","unstructured":"Hao F, Fei X, Ren X, Xi Xiao J, Chen Y, Wang J. Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial-mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4. J Cellul Mol Med. 2020;24(20):11779\u201390.","journal-title":"J Cellul Mol Med"},{"key":"2475_CR24","doi-asserted-by":"publisher","first-page":"855078","DOI":"10.3389\/fimmu.2022.855078","volume":"13","author":"C Zhong","year":"2022","unstructured":"Zhong C, Xie Z, Zeng L, Yuan C, Duan S. MIR4435\u20132HG is a potential pan-cancer biomarker for diagnosis and prognosis. Front Immunol. 2022;13:855078.","journal-title":"Front Immunol"},{"key":"2475_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biopha.2017.03.031","volume":"90","author":"X Deng","year":"2017","unstructured":"Deng X, Zhao X, Liang X, Chen R, Pan Y, Liang J. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Biomed Pharmacother. 2017;90:100\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2475_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1159\/000430387","volume":"37","author":"J Li","year":"2015","unstructured":"Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, et al. HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma. Cellul Physiol Biochem. 2015;37(2):687\u201396.","journal-title":"Cellul Physiol Biochem"},{"issue":"4","key":"2475_CR27","first-page":"2547","volume":"18","author":"H Ouyang","year":"2019","unstructured":"Ouyang H, Zhang L, Xie Z, Ma S. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852. Exp Therap Med. 2019;18(4):2547\u201353.","journal-title":"Exp Therap Med"},{"issue":"6","key":"2475_CR28","first-page":"3625","volume":"40","author":"Y Chang","year":"2018","unstructured":"Chang Y, Zhang J, Zhou C, Qiu G, Wang G, Wang S, et al. Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR-206. Oncol Rep. 2018;40(6):3625\u201334.","journal-title":"Oncol Rep"},{"key":"2475_CR29","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s13277-015-4052-4","volume":"37","author":"T Zhang","year":"2016","unstructured":"Zhang T, Cao C, Wu D, Liu L. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. Tumor Biol. 2016;37:2379\u201385.","journal-title":"Tumor Biol"},{"key":"2475_CR30","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2147\/CMAR.S182001","volume":"11","author":"Y-L Huang","year":"2019","unstructured":"Huang Y-L, Ning G, Chen L-B, Lian Y-F, Gu Y-R, Wang J-L, et al. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma. Cancer Manag Res. 2019;11:1725.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"2475_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","volume":"60","author":"MS Matter","year":"2014","unstructured":"Matter MS, Decaens T, Andersen JB, Thorgeirsson SS. Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatolgy. 2014;60(4):855\u201365.","journal-title":"J Hepatolgy"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02475-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T10:30:10Z","timestamp":1747305010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2475"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02475-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were conducted according to the pertinent guidelines and regulations of the Ministry of Health and Medical Education of Iran. The Biomedical Ethics Committee of the Islamic Azad University of Shahrekord (No.IR.IAU.SHK.REC.1402.072) approved all procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors support the submission of the present manuscript to this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"771"}}